NCT05388669 · Interventional trial
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Overall registry status Active not recruiting
Phase 3
Conditions Advanced or Metastatic Non-small Cell Lung Cancer
Delaware Valley sites
- University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory